<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03180073</url>
  </required_header>
  <id_info>
    <org_study_id>17-086</org_study_id>
    <nct_id>NCT03180073</nct_id>
  </id_info>
  <brief_title>Conduction Abnormalities With Severe Aortic Stenosis Before and After Transcatheter Aortic Valve Replacement</brief_title>
  <official_title>Prevalence and Significance of Bradycardic Arrhythmias and Conduction Abnormalities Among Patients With Severe Aortic Stenosis Before and After Transcatheter Aortic Valve Replacement Using Extended Heart Rhythm Recording (Brady-TAVR Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Most of the conduction abnormalities with TAVR are usually detected during the procedure or
      during the following days of observation. Little is known about the prevalence and timing of
      any conduction abnormalities that exist before (other than standard ECG) or after through
      long term cardiac monitoring.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Each subject who fulfills the inclusion/exclusion criteria will be provided with Zio patch
      for 2 weeks before TAVR. Immediately after the procedure, patients will be admitted per TAVR
      protocol and will be on telemetry. Data about their ECGs and any arrhythmias will be
      collected.

      Upon discharge, patients will be provided with another Zio patch for 2 weeks. At the 2-3
      months follow up, subjects will be provided with a third Zio patch for 2 weeks
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 6, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Need for Pacemaker post TAVR</measure>
    <time_frame>2 months prior to TAVR</time_frame>
    <description>the prevalence of brady arrhythmia (Sinus brady, Sinus Pauses, AV Block, Bundle Branch Block) among patients with severe aortic stenosis who undergo TAVR using an extended cardiac rhythm monitor (Zio Patch) and determine if the brady arrhythmias predict the need for a pacemaker.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of in hospital brady arrhythmia post TAVR</measure>
    <time_frame>72 hours post TAVR</time_frame>
    <description>the prevalence of brady arrhythmia (Sinus brady, Sinus pause, AV block, Bundle branch block) using hospital telemetry data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of brady arrhythmia after discharge from hospital post TAVR</measure>
    <time_frame>3 weeks post discharge</time_frame>
    <description>the prevalence of brady arrhythmia (Sinus brady, Sinus pauses, AV block, Bundle branch block) using extended cardiac rhythm monitor (Zio Patch)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of delayed brady arrhythmia post TAVR</measure>
    <time_frame>2 months post TAVR</time_frame>
    <description>the prevalence of brady arrhythmia using extended cardiac rhythm Assess the prevalence of brady arrhythmia (Sinus brady, Sinus Pause, AV block, Bundle branch block) using extended cardiac rhythm monitor (Zio Patch)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Bradycardia</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Ziopatch Pre discharge</intervention_name>
    <description>Ziopatch applied 2 weeks prior to procedure</description>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Ziopatch at Discharge</intervention_name>
    <description>Ziopatch applied at discharge from hospital to be worn for 2 weeks</description>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Ziopatch at 2 months</intervention_name>
    <description>Ziopatch applied 2 months from procedure to be worn for 2 weeks</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients to be scheduled for TAVR without preexisting Cardiac Implantable Electronic Device
        (CIED) can be screen and enrolled
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age &gt; 18 and &lt;90 years old

          2. Able to provide informed consent

          3. Willing to follow up at Cleveland Clinic (per TAVR protocol)

        Exclusion Criteria:

          1. Prior CIED (Pacemaker or defibrillator)

          2. Unable to provide consent

          3. Unable to follow up at Cleveland Clinic per TAVR protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Khaldoun Tarakji, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>khaldoun Tarakji, MD</last_name>
    <phone>216-445-9225</phone>
    <email>tarakjk@ccf.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Khaldoun Tarakji, MD</last_name>
      <phone>216-445-9225</phone>
      <email>Tarakjk@ccf.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 9, 2017</study_first_submitted>
  <study_first_submitted_qc>June 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 8, 2017</study_first_posted>
  <last_update_submitted>May 14, 2018</last_update_submitted>
  <last_update_submitted_qc>May 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>Khaldoun Tarakji</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
    <mesh_term>Bradycardia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

